A case of deficiency of N‐hydroxylation of amobarbital
- 1 May 1977
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 21 (5), 530-535
- https://doi.org/10.1002/cpt1977215530
Abstract
It has been shown recently that the overall metabolism of amobarbital in man is essentially under genetic control. The drug normally undergoes two hydroxylation reactions, leading to 3′-hydroxyamobarbital (C-OH) and N-hydroxyamobarbital (N-OH). This paper describes a sibship in which two mothers who are identical twins show a gross deficiency on N-OH elimination in urine. The whole set of sibship data suggests that this deficiency represents a recessive trait controlled by a single pair of allelic autosomal genes which regulate N-OH formation. Several methodical approaches to assess an individual's capacity for N-OH formation are illustrated. There was no evidence of compensatory or concordant regulation of the two hydroxylation reactions. The case of this family illustrates that the functional lack of a biotransformation reaction is almost certain to be overlooked if one measures only the disappearance of a multimetabolized drug and not the appearance of metabolites.This publication has 8 references indexed in Scilit:
- Genetic study of amobarbital elimination based on its kinetics in twinsClinical Pharmacology & Therapeutics, 1976
- Amobarbital—a probe of hepatic drug oxidation in manClinical Pharmacology & Therapeutics, 1976
- Amylobarbitone Hydroxylation Kinetics in Small Samples of Rat and Human LiverXenobiotica, 1976
- Genetic Control of Drug Levels in Man: AntipyrineScience, 1968
- Genetic Control of Drug Levels in Man: PhenylbutazoneScience, 1968
- Insufficient parahydroxylation as a cause of diphenylhydantoin toxicityNeurology, 1964
- ON DISTRIBUTION AND INHERITANCE OF ATYPICAL FORMS OF HUMAN SERUM CHOLINESTERASE, AS INDICATED BY DIBUCAINE NUMBERSCanadian Journal of Biochemistry and Physiology, 1957
- ON THE METABOLIC FATE OF ISONIAZID1953